Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	103.76	55.29	44.7	120.39	198.05	19.24
Cash & Short-Term Investments	103.76	55.29	44.7	120.39	198.05	19.24
Cash Growth	69.39%	23.68%	-62.87%	-39.22%	929.49%	-60.61%
Other Receivables	-	2	-	-	-	-
Receivables	17.5	2	-	-	-	-
Prepaid Expenses	2.83	2.94	3.42	4.11	4.46	1.35
Total Current Assets	124.09	60.23	48.13	124.5	202.52	20.59
Property, Plant & Equipment	7.8	9.06	11.2	13.06	13.9	14.06
Other Long-Term Assets	1.8	1.78	1.6	1.61	1.64	1.66
Total Assets	133.69	71.08	60.93	139.17	218.06	36.32
Accounts Payable	2.3	2.57	1.05	3.13	3.14	5.44
Accrued Expenses	8.95	9.98	10.5	10.33	8.75	13.73
Current Portion of Long-Term Debt	-	-	3.32	6.67	-	2.33
Current Portion of Leases	1.3	1.19	1.1	1	0.88	0.65
Current Unearned Revenue	43.85	13.52	-	-	-	-
Total Current Liabilities	56.4	27.26	15.96	21.12	12.78	22.16
Long-Term Debt	-	-	-	3.17	9.63	7.81
Long-Term Leases	5.96	6.95	8.14	9.23	10.23	11.1
Long-Term Unearned Revenue	25.5	19.26	-	-	-	-
Other Long-Term Liabilities	53.93	-	-	-	-	0.54
Total Liabilities	141.79	53.48	24.1	33.52	32.63	41.6
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	421.05	401.35	362.34	354.75	346.31	1.8
Retained Earnings	-429.15	-383.75	-325.51	-249.11	-160.89	-85.09
Total Common Equity	-8.1	17.6	36.83	105.65	185.43	-83.29
Shareholders' Equity	-8.1	17.6	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	133.69	71.08	60.93	139.17	218.06	36.32
Total Debt	7.26	8.14	12.55	20.07	20.74	21.89
Net Cash (Debt)	96.5	47.15	32.15	100.32	177.32	-2.65
Net Cash Growth	82.62%	46.64%	-67.95%	-43.42%	-	-
Net Cash Per Share	1.01	0.88	1.17	3.66	31.63	-5.06
Filing Date Shares Outstanding	52.5	51.77	34.47	27.43	27.36	0.81
Total Common Shares Outstanding	51.83	45.76	27.61	27.43	27.36	0.81
Working Capital	67.69	32.97	32.17	103.38	189.74	-1.57
Book Value Per Share	-0.16	0.38	1.33	3.85	6.78	-103.39
Tangible Book Value	-8.1	17.6	36.83	105.65	185.43	-83.29
Tangible Book Value Per Share	-0.16	0.38	1.33	3.85	6.78	-103.39
Machinery	7.02	6.78	6.68	6.45	4.67	3.64
Construction In Progress	-	-	-	0.1	0.54	-
Leasehold Improvements	5.12	5.12	5.12	5.12	5.12	5.09

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q